Criteria Bio Ventures
Avinguda Diagonal, 621, Torre II, Barcelona, CT, 08028, Spain
Overview
Venture fund backing private biotech companies in Europe and North America.
Founded
2007
Deals · 12mo
2
Stage focus
Geographic focus
Sector focus
Investment portfolio
| NAME | DATE | SIZE | |
|---|---|---|---|
Cytospire Therapeutics | May 2026Participated | $83 MSeries A | |
Adaptam Therapeutics | Oct 2025Led | $3 MSeed | |
NRG Therapeutics | Sep 2025Participated | $67 MSeries B | |
Tolerance Bio | Oct 2024Participated | $17 MSeed | |
Cytospire Therapeutics | May 2026Participated | $83 MSeries A | |
Adaptam Therapeutics | Oct 2025Led | $3 MSeed | |
NRG Therapeutics | Sep 2025Participated | $67 MSeries B | |
Tolerance Bio | Oct 2024Participated | $17 MSeed |
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Seed | 1 | 1 |
| Series A | 0 | 1 |
| Series B | 0 | 1 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| Oct '24 | 1 |
| Nov '24 | 0 |
| Dec '24 | 0 |
| Jan '25 | 0 |
| Feb '25 | 0 |
| Mar '25 | 0 |
| Apr '25 | 0 |
| May '25 | 0 |
| Jun '25 | 0 |
| Jul '25 | 0 |
| Aug '25 | 0 |
| Sep '25 | 1 |
| Oct '25 | 1 |
| Nov '25 | 0 |
| Dec '25 | 0 |
| Jan '26 | 0 |
| Feb '26 | 0 |
| Mar '26 | 0 |
| Apr '26 | 0 |
| May '26 | 1 |
| Jun '26 | 0 |
| Jul '26 | 0 |
| Aug '26 | 0 |
| Sep '26 | 0 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 4 |
| Space & Frontier Tech | 1 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 1 |
| $5M-$10M | 0 |
| $10M-$25M | 1 |
| $25M-$50M | 0 |
| $50M-$100M | 2 |
| $100M-$250M | 0 |
| $250M-$500M | 0 |
| $500M-$1B | 0 |
| $1B+ | 0 |
Deals By Geography
Top 2 of 2 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| Europe | 3 |
| 27517 | 1 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| British Business Bank | 2 |
| 4BIO Capital | 1 |
| Abingworth | 1 |
| Ben Franklin Technology Partners | 1 |
| BioAdvance | 1 |
| Brandon Capital | 1 |
| Columbus Venture Partners | 1 |
| LifeArc | 1 |
| M Ventures | 1 |
| Medical Incubator Japan | 1 |
| Modi Ventures | 1 |
| Novartis | 1 |
| Omega Funds | 1 |
| Pathway BioVentures | 1 |
| Servier | 1 |
| Sessa Capital | 1 |
| Sound Bioventures | 1 |
| SV Health Investors | 1 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 1 | 25% |
| Participating | 3 | 75% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 1 | 100% |
| Co-led | 0 | 0% |